No abstract available
Keywords:
berotralstat; comparative effectiveness; hereditary angioedema; indirect treatment comparison; lanadelumab; prophylaxis.
Publication types
-
Letter
-
Meta-Analysis
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Angioedemas, Hereditary* / drug therapy
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized* / therapeutic use
-
Humans
-
Meta-Analysis as Topic
-
Network Meta-Analysis
Substances
-
Antibodies, Monoclonal, Humanized
-
lanadelumab
-
Antibodies, Monoclonal